R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2022
Back to search
Official data from USPTO
LA MEDIZONA PHARMACY & LIQUOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/08/2022
Trademark type
Combined
Nice classes
35
Filing date
12/02/2019
Registration date
03/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/08/2022
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2019
First use in commerce
11/01/2020
Drawing code
3
Owner type
16
Owner location
HOUSTON, TX
Examiner
GARDNER, BERYL
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LA MEDIZONA" above the smaller stylized wording "PHARMACY & LIQUOR". The letters "LA MEDI" are blue and the letters "ZONA" are red. The wording "PHARMACY &" are blue and the wording "LIQUOR" is red. The dot above the letter "I" in "MEDI" is a design of a location pin outlined in blue on the left side and red on the right side. The pin head is white and centered inside the head is a red and white pill capsule.
Holders and representatives
Holders
La Medizona Pharmacy Corporation LLC
Representatives
BLANCA ARBOUR
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services
Publications
History of USPTO decisions and trademark events.
39 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/01/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/29/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/04/2021
GNFR
FINAL REFUSAL E-MAILED
07/04/2021
CNFR
SU - FINAL REFUSAL - WRITTEN
07/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/19/2021
GNRT
NON-FINAL ACTION E-MAILED
01/19/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/19/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/12/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/12/2020
IUAF
USE AMENDMENT FILED
12/03/2020
EISU
TEAS STATEMENT OF USE RECEIVED
12/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2020
PUBO
PUBLISHED FOR OPPOSITION
05/26/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/21/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/21/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/21/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2020
ALIE
ASSIGNED TO LIE
04/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2020
GNRT
NON-FINAL ACTION E-MAILED
03/13/2020
CNRT
NON-FINAL ACTION WRITTEN
03/13/2020
DOCK
ASSIGNED TO EXAMINER
03/03/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/07/2019
NWAP
NEW APPLICATION ENTERED
12/05/2019
Continuous trademark protection
Get notified about every new filing that threatens LA MEDIZONA PHARMACY & LIQUOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.